Canada's Competition Bureau says preferred provider networks may lessen competition

( November 4, 2024, 15:53 GMT | Official Statement) -- MLex Summary: The use of preferred provider networks, and in particular closed and mandatory PPNs appears on its face to reduce patient choice by effectively limiting the sale of certain drugs to specific pharmacies, and may lessen competition, Canada’s Competition Bureau said in a submission to the Ontario Ministry of Finance. “Even if PPNs result in overall cost savings, these arrangements could also disproportionately impact certain participants in insurance and pharmacy markets, including independent pharmacies, seniors, and patients who live in rural or remote parts of the country. If PPNs or similar arrangements become more commonplace, there is a corresponding risk that consumer choice may become increasingly limited,” its aid.See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.

Know what others in the room don’t, with features including:

Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Canada's Competition Bureau says preferred provider networks may lessen competition

Prepare for tomorrow’s regulatory change, today

Documents

Related Sections